The Department for Promotion of Industry and Internal Trade (DPIIT) stepped in to change the conditions of tenders in order to promote 'Made in India' goods, a top official said.
Researchers are interested in exploring whether the drug could help nip cancer in the bud at early stages.
Therapiva is a joint venture between Omnicare Drugs India, a wholly owned subsidiary of Neopharma LLC, Abu Dhabi and Laxai Life Sciences.
Insurance penetration in the country reached 3.7 percent in 2017 from 2.71 percent in 2001.
Cabinet nod for 100% FDI in single brand retail via automatic route; 49% in Air India through approval
Foreign investment(s) in Air India including that of foreign Airline(s) shall not exceed 49 percent either directly or indirectly
The report is the second edition and analysed 160 India-based companies across pharmaceuticals, medical devices equipment, diagnostics and hospitals.
Big data analytics in healthcare: Fuelled by wearables and apps, medical research takes giant leap forward
Big data analytics has decreased the time required to double medical knowledge by half, thus compressing healthcare innovation cycle period
The API division had a turnover of Rs 712.2 crore in 2015-16
Four workers were charred to death when a reactor exploded in manufacturing unit of pahramceutical firm in Maheswaram on the outskirts of Hyderabad on Monday, police said.
This is the biggest and the most ambitious healthcare policy ever formulated
Profits and patents go hand in hand in this debate. Nadda would do well keeping this in mind.
The National Pharmaceutical Pricing Authority (NPPA) had invoked Para 19 of the Drug Prices Control Order (DPCO) to cap prices of 108 cardiac and diabetes drugs on July 10. <br />
Pharmaceutical firm Cipla today announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.
The Supreme Court today raised a question on the new Drug Price Control Order (DPCO) of the Centre to fix the ceiling price of essential medicines on the basis of market-based pricing
Dr Reddy's Laboratories has decided to acquire Netherlands-based OctoPlus NV, a speciality pharmaceutical company, for about 27.4 million euros
Launches Global Authentication Service, a cloud-based track-and-trace solution to fight drug counterfeiting